✦ LIBER ✦

Clinical, endocrine, and metabolic effects of two doses of gestrinone in treatment of pelvic endometriosis

✍ Scribed by M.Yusoff Dawood; Charles W. Obasiolu; Josefina Ramos; Firyal S. Khan-Dawood

Book ID: 113984449
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 795 KB
Volume: 176
Category: Article
ISSN: 1097-6868
DOI: 10.1016/s0002-9378(97)70504-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale for frequency and dose of admi

Rationale for frequency and dose of administration in gestrinone therapy for pelvic endometriosis in the experimental model of rabbit uterus

✍ Tamaya, Teruhiko; Wada, Keisuke; Imai, Atsushi; Mori, Hidehiro; Ban, Hideaki 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 459 KB

Endocrine effects of danazol in the trea

Endocrine effects of danazol in the treatment of endometriosis

✍ J. R. BEVAN; M. DOWSETT; S. L. JEFFCOATE 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB

CLINICAL AND METABOLIC EFFECTS OF DIFFER

CLINICAL AND METABOLIC EFFECTS OF DIFFERENT DOSES OF PROSTAGLANDIN E1 IN MAN

✍ Carlson, Lars A. ;Ekelund, Lars-Göran ;Orö, Lars 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 654 KB

Endocrine, Metabolic and Clinical Effect

Endocrine, Metabolic and Clinical Effects of Intravenous Endotoxin Injection after Pre-Treatment with Meloxicam in Heifers

✍ KONIGSSON, K. ;ODENSVIK, K. ;KINDAHL, H. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

Treatment of metastatic breast cancer pa

Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects

✍ Alexieva-Figusch, J.; Blankenstein, M.A.; Hop, W.C.J.; Klijn, J.G.M.; Lamberts, 📂 Article 📅 1984 🏛 Elsevier Science ⚖ 865 KB

Haemodynamic, metabolic and endocrine ef

Haemodynamic, metabolic and endocrine effects of short-term dexfenfluramine treatment in young, obese women

✍ B. Andersson; M. E. Zimmermann; T. Hedner; P. Björntorp 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 667 KB

Seventeen normotensive, premenopausal women were treated with the 5-hydroxytryptamine-reuptake inhibitor dexfenfluramine 30 mg per day, for 4 days in a randomised double-blind, cross-over, placebo controlled trial. Energy intake was held constant during the study as the aim was to study the endocrin